Seeing Is Believing

Currently out of the existing stock ratings of Raymond Myers, 7 are a BUY (70%), 3 are a HOLD (30%).
Analyst Raymond Myers, carries an average stock price target met ratio of 100% that have a potential upside of 29.49% achieved within 211 days. Previously, Raymond Myers worked at BENCHMARK.
Raymond Myers’s has documented 24 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on HSKA, Heska at 07-May-2018.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/31/2017. The price target of $60 was fulfilled within 7 days with a profit of $5.01 (9.11%) receiving and performance score of 13.02.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 09-Jul-2021
$105
$3.26 (3.20%)
$75
1 months 15 days ago
(25-Nov-2025)
9/13 (69.23%)
$3.87 (3.83%)
406
Buy
Since 31-May-2013
$105
$3.26 (3.20%)
$85
1 months 16 days ago
(24-Nov-2025)
21/24 (87.5%)
$3.99 (3.95%)
203
Buy
Since 02-Jan-2024
$75
1 months 16 days ago
(24-Nov-2025)
14/14 (100%)
$8.02 (11.97%)
205
Buy
Since 23-Jan-2025
$105
$3.26 (3.20%)
$77
1 months 19 days ago
(21-Nov-2025)
8/9 (88.89%)
$4.1 (4.06%)
126
Buy
Since 10-Oct-2023
$80
$-21.74 (-21.37%)
$70
1 months 29 days ago
(11-Nov-2025)
13/13 (100%)
$12.5 (18.52%)
284
What Year was the first public recommendation made by Raymond Myers?